|
July
Tuesday, Jul 20, 2010 Genentech Provides Update From Avastin FDA Advisory Committee Meeting Tuesday, Jul 06, 2010 Genentech Submits Application to FDA for Trastuzumab-DM1 in Previously Treated Advanced HER2-Positive Breast Cancer Thursday, Jul 01, 2010 Second Phase III Study Showed Avastin-Containing Regimen Helped Women with Ovarian Cancer Live Longer Without their Disease Getting Worse June Tuesday, Jun 22, 2010 FDA Approves Lucentis® (Ranibizumab Injection) for the Treatment of Macular Edema Following Retinal Vein Occlusion Sunday, Jun 06, 2010 Phase III Study Showed Avastin-Based Regimen Helped Women with Advanced Ovarian Cancer Live Longer Without Their Disease Worsening Thursday, Jun 03, 2010 Genentech's Scheller Wins Kavli Prize in Neuroscience May Thursday, May 20, 2010 Roche and Genentech to Present New Data on Different Approaches to Treating Cancer at ASCO Thursday, May 20, 2010 Phase III Study Showed First-Line Maintenance Use of Rituxan® Improved the Likelihood of People with Follicular Lymphoma Living without Their Disease Worsening See the Archives 
 |
